The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the MPM Bio IV NVS Strategic Fund, startups are often financed by Wellcome Trust, Scottish Widows Investment Partnership, MPM Capital. The meaningful sponsors for the fund in investment in the same round are MPM Capital, BB Biotech Ventures, Wellcome Trust. In the next rounds fund is usually obtained by MPM Capital, BB Biotech Ventures, Wellcome Trust.
The real fund results show that this VC is 5 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 deals per year. The top amount of exits for fund were in 2014. This MPM Bio IV NVS Strategic Fund works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2009. The common things for fund are deals in the range of 10 - 50 millions dollars.
Among the various public portfolio startups of the fund, we may underline Proteon Therapeutics, Radius Health Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical, Health Care. The fund has no specific favorite in a number of founders of portfolio startups.
Related Funds
Fund Name | Location |
3S Landing Pad | California, San Francisco, United States |
Aspire Systems | Chennai, India, Tamil Nadu |
Base Case Capital | California, San Francisco, United States |
Beiqing Ruichuang | Beijing, Beijing Shi, China |
Cedarville Investments | Arkansas, Arkansas City, United States |
Cooley | California, Palo Alto, United States |
Essel Group | India, Maharashtra, Mumbai |
Groupe Bertrand | France, Ile-de-France, Paris |
Itera Capital | Distrito Federal, Mexico, Mexico City |
K2 Investment Partners | Seoul, Seoul-t'ukpyolsi, South Korea |
Lauder Partners | Atherton, California, United States |
ProMutual Group Inc | - |
Salt Lake Life Science Angels | Salt Lake City, United States, Utah |
The Vinetta Project | California, Los Angeles, United States |
Tunisian American Enterprise Fund | District of Columbia, United States, Washington |
Whole Foods Market | Austin, Texas, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Proteon Therapeutics | $50M | 28 May 2009 | Massachusetts, United States | ||
Radius Health | $15M | 20 Nov 2008 | Cambridge, Massachusetts, United States | ||
Radius Health | $10M | 17 Sep 2007 | Cambridge, Massachusetts, United States | ||
AVEO Oncology | $5M | 05 May 2005 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Proteon Therapeutics | $50M | 28 May 2009 | Massachusetts, United States | ||
Radius Health | $15M | 20 Nov 2008 | Cambridge, Massachusetts, United States | ||
Radius Health | $10M | 17 Sep 2007 | Cambridge, Massachusetts, United States | ||
AVEO Oncology | $5M | 05 May 2005 | Cambridge, Massachusetts, United States |